why choose us

First received: August 20, 2026

Clinical Trial: Comparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatitis B
ESRD (End Stage Renal Disease)
Kidney Failure
Chronic

Study Type: INTERVENTIONAL


Official Title: COMPARISON OF EFFICACY OF TWO IMMUNIZATION SCHEDULES (3 VS 4 DOSES) WITH RECOMBINANT HEP B VACCINE IN PATIENTS ON MAINTENANCE HEMODIALYSIS (MHD)

Brief Summary: People with kidney failure who are on dialysis have a weaker immune response to the hepatitis B vaccine than healthy people. Even after vaccination, many dialysis patients do not develop enough protection against hepatitis B infection. Doctors do not agree on whether giving 3 doses or 4 doses of the vaccine works better for these patients.This study will compare two vaccination schedules using a stronger (double) dose of the hepatitis B vaccine in people on maintenance hemodialysis:Group 1 will receive 3 doses of…

Read more